General Internal Medicine

Oliver Kent Glass, PhD

Assistant Professor in Medicine
Assistant Professor in Pathology
Campus mail 3475 Erwin Rd., Durham, NC 27710
Phone (919) 660-6672
Email address oliver.glass@duke.edu

My research interests are understanding how and why exercise is effective in chronic disease. I am interested in the unique role of skeletal muscle as a key mediator of exercise effects. 

Education and Training

  • Ph.D., Duke University, 2015

Grants

Publications

Hartman, Zachary C., Junping Wei, Takuya Osada, Oliver Glass, Gangjun Lei, Xiao-Yi Yang, Sharon Peplinski, et al. “An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity.” Clin Cancer Res 16, no. 5 (March 1, 2010): 1466–77. https://doi.org/10.1158/1078-0432.CCR-09-2549.

PMID
20179231
Full Text

Osada, T., X. Y. Yang, Z. C. Hartman, O. Glass, B. L. Hodges, D. Niedzwiecki, M. A. Morse, H. K. Lyerly, A. Amalfitano, and T. M. Clay. “Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.” Cancer Gene Ther 16, no. 9 (September 2009): 673–82. https://doi.org/10.1038/cgt.2009.17.

PMID
19229288
Full Text

Hartman, Zachary C., Daniel M. Appledorn, Delila Serra, Oliver Glass, Todd B. Mendelson, Timothy M. Clay, and Andrea Amalfitano. “Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system.” Virology 374, no. 2 (May 10, 2008): 453–67. https://doi.org/10.1016/j.virol.2008.01.017.

PMID
18280530
Full Text

Pages